{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "08/24/2026",
      "update_type": "New",
      "initial_posting_date": "08/24/2026",
      "package_ndc": "0025-2732-31",
      "generic_name": "Disopyramide Phosphate Capsule, Extended Release",
      "contact_info": "800-533-4535",
      "related_info": "Discontinuation of the manufacture of the drug",
      "update_date": "08/24/2026",
      "therapeutic_category": [
        "Cardiovascular"
      ],
      "dosage_form": "Capsule, Extended Release",
      "presentation": "Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31)",
      "company_name": "Pfizer Inc.",
      "status": "To Be Discontinued"
    }
  ]
}